These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 17363091)

  • 1. Cardiovascular effects of Danshen.
    Cheng TO
    Int J Cardiol; 2007 Sep; 121(1):9-22. PubMed ID: 17363091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion.
    Han JY; Fan JY; Horie Y; Miura S; Cui DH; Ishii H; Hibi T; Tsuneki H; Kimura I
    Pharmacol Ther; 2008 Feb; 117(2):280-95. PubMed ID: 18048101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Danshen (Salvia miltiorrhiza Bunge): A Prospective Healing Sage for Cardiovascular Diseases.
    Chen W; Chen G
    Curr Pharm Des; 2017; 23(34):5125-5135. PubMed ID: 28828985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvia miltiorrhiza and ischemic diseases.
    Ji XY; Tan BK; Zhu YZ
    Acta Pharmacol Sin; 2000 Dec; 21(12):1089-94. PubMed ID: 11603281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herb-drug interactions with Danshen (Salvia miltiorrhiza): a review on the role of cytochrome P450 enzymes.
    Zhou X; Chan K; Yeung JH
    Drug Metabol Drug Interact; 2012 Mar; 27(1):9-18. PubMed ID: 22718621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvia miltiorrhiza treatment during early reperfusion reduced postischemic myocardial injury in the rat.
    Nie R; Xia R; Zhong X; Xia Z
    Can J Physiol Pharmacol; 2007 Oct; 85(10):1012-9. PubMed ID: 18066102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use.
    Zhou L; Zuo Z; Chow MS
    J Clin Pharmacol; 2005 Dec; 45(12):1345-59. PubMed ID: 16291709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roots of Salvia miltiorrhiza (Danshen) and Pueraria lobata (Gegen) inhibit atherogenic events: a study of the combination effects of the 2-herb formula.
    Wing-Shing Cheung D; Koon CM; Ng CF; Leung PC; Fung KP; Kar-Sing Poon S; Bik-San Lau C
    J Ethnopharmacol; 2012 Oct; 143(3):859-66. PubMed ID: 22922086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases.
    Wang L; Ma R; Liu C; Liu H; Zhu R; Guo S; Tang M; Li Y; Niu J; Fu M; Gao S; Zhang D
    Curr Pharm Des; 2017; 23(7):1077-1097. PubMed ID: 27748194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Network pharmacology study on major active compounds of Fufang Danshen formula].
    Li X; Wu L; Fan X; Zhang B; Gao X; Wang Y; Cheng Y
    Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(21):2911-5. PubMed ID: 22308672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Danshen: a popular chinese cardiac herbal drug.
    Cheng TO
    J Am Coll Cardiol; 2006 Apr; 47(7):1498; author reply 1499-500. PubMed ID: 16580549
    [No Abstract]   [Full Text] [Related]  

  • 12. [Platelet antiaggregants in the treatment of vasculopathies].
    Honorato J; Montes-Jovellar B
    Angiologia; 1990; 42(1):1-10. PubMed ID: 2181892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular disease: medical therapy, surgery and interventional technologies.
    Korr KS
    Med Health R I; 2008 Oct; 91(10):300. PubMed ID: 19044103
    [No Abstract]   [Full Text] [Related]  

  • 14. Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics.
    Li ZM; Xu SW; Liu PQ
    Acta Pharmacol Sin; 2018 May; 39(5):802-824. PubMed ID: 29698387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvia miltiorrhiza: Traditional medicinal uses, chemistry, and pharmacology.
    Su CY; Ming QL; Rahman K; Han T; Qin LP
    Chin J Nat Med; 2015 Mar; 13(3):163-82. PubMed ID: 25835361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of platelet and leucocyte function by a Chinese herbal formulation as compared with conventional antiplatelet agents.
    Zhao L; Gaudry L; Dunkley S; Brighton T; Guo ZX; Ye ZL; Luo RZ; Chesterman CN
    Platelets; 2008 Feb; 19(1):24-31. PubMed ID: 18231935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on rat CYP1A2 expression and metabolism of model CYP1A2 probe substrates.
    Wang X; Lee WY; Or PM; Yeung JH
    Phytomedicine; 2009 Aug; 16(8):712-25. PubMed ID: 19403289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical characteristics of Salvia miltiorrhiza (Danshen) collected from different locations in China.
    Zhong GX; Li P; Zeng LJ; Guan J; Li DQ; Li SP
    J Agric Food Chem; 2009 Aug; 57(15):6879-87. PubMed ID: 19601629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components.
    Wu WY; Wang YP
    Acta Pharmacol Sin; 2012 Sep; 33(9):1119-30. PubMed ID: 22941285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet therapy after endovascular intervention: does combination therapy really work and what is the optimum duration of therapy?
    Milani RV
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S7-S11. PubMed ID: 19213064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.